Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Trial for Endometriosis

A Phase 3B Study to Evaluate Bone Mineral Density with Long-Term Use of the Investigational Medication in Women with Moderate to Severe Pain due to Endometriosis

physician talking with patient

 

AGE: 18 - 50 years old
SEX AT BIRTH: Female
HEALTHY PARTICIPANTS: No
TYPE: Interventional Drug Study
CONDITION: Endometriosis
LOCATION: UH Landerbrook Medical Center and UH Ahuja Risman Medical Center

Learn More About This Research Study

For more information, please contact the study nurse coordinator, Bridget Ermlich, RN, at 216-844-8091 or complete the form below.

Study Purpose

The purpose of this research study is to characterize changes in bone mineral density during continuous treatment with the investigational medication for up to 48 months (4 years) and 1 year of post-treatment follow-up in premenopausal women with moderate-to-severe pain associated with endometriosis.

Who Can Participate

Premenopausal women aged 18 – 50 years, who have a diagnosis of moderate to severe pain associated with endometriosis may be eligible to participate.

Request More Information

Please complete the form below to be contacted by a study representative and learn more about this study,

I'm not a robot